CATEGORIES

Industry News

LATEST

TRENDING

EDITORS CHOICE

Treatment for Schizophrenia and Bipolar I Disorder Gets Vote of Support

The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Clinical results in primary and secondary endpoints for 6- and 12-week experimental smoking cessation treatment reported by company sponsor.

Ivermectin is Dead and Buried Despite NIH Website Misstep and Twitter Buzz

Ivermectin is a global con, sold by unscrupulous doctors and healthcare professionals as a treatment for Covid. It doesn't work.

ACOG Statement on the Johnson & Johnson COVID-19 Vaccine

ACOG issues a statement to its members on the temporary withdrawal of the Johnson & Johnson vaccine following reports of rare blood clotting condition.